Integra LifeSciences Holdings (IART)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,608,880 | 1,486,360 | 1,506,670 | 1,533,950 | 1,298,690 |
| Total current assets | US$ in thousands | 1,081,680 | 1,058,040 | 1,161,500 | 1,153,720 | 1,237,200 |
| Total current liabilities | US$ in thousands | 922,126 | 306,980 | 320,906 | 340,021 | 401,013 |
| Working capital turnover | 10.08 | 1.98 | 1.79 | 1.89 | 1.55 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,608,880K ÷ ($1,081,680K – $922,126K)
= 10.08
The working capital turnover for Integra LifeSciences Holdings has shown a fluctuating trend over the years. It increased from 1.55 in 2020 to 1.89 in 2021, indicating a more efficient utilization of its working capital to generate revenue. However, in 2022, the working capital turnover slightly dropped to 1.79 before picking up again to 1.98 in 2023. The most significant increase was observed in 2024, where the working capital turnover surged to an impressive 10.08, suggesting a substantial improvement in the company's working capital management efficiency. Overall, the trend indicates a varying but generally positive performance in terms of how effectively the company is utilizing its working capital to generate sales revenue.
Peer comparison
Dec 31, 2024